← European Medicine Shortage Tracker · all medicines
Rasburicase currently has availability issues reported in 1 European register: Ireland.
Shortage ATC — · also listed as: rasburicase · data refreshed 7 August 2026
As of 7 August 2026, 1 of the 10 tracked registers list current availability issues for Rasburicase, covering 1 affected product presentation. The longest-running open report was filed in Ireland on 2026-05-18 and has now been open for about 3 months. Where agencies state a cause, quality issues lead with 1 of the 1 stated-cause reports. Notably, 1 report has already passed the expected-resolution date without closing — prognoses for this medicine should be read as estimates, not commitments. Registers in Ireland indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.
| Where | Status & products | Since | Expected end | Reason / alternatives | Source |
|---|---|---|---|---|---|
| 🇪🇺 EU-wide (EMA) | Resolved Fasturtec (rasburicase) | 2023-03-31 | — | Hyperuricemia | register ↗ |
| 🇮🇪 Ireland | Shortage Fasturtec 1.5 mg / ml powder and solvent for concentrate for solution fo | 2026-05-18 | 2026-06-10 | Quality issue (Multiple countries) Alternatives: No authorised alternative listed. | register ↗ |
Every individual register entry for Rasburicase in the tracked sources, newest first — including resolved and discontinued reports.
| Reg. | Product | Status | Reported | Expected end | Stated reason |
|---|---|---|---|---|---|
| 🇮🇪 IE | Fasturtec 1.5 mg / ml powder and solvent for concentrate for solution | Shortage | 2026-05-18 | 2026-06-10 | Quality issue (Multiple countries) |
| 🇪🇺 EU | Fasturtec (rasburicase) | Resolved | 2023-03-31 | — | Hyperuricemia |
Yes. As of 7 August 2026, availability issues are reported in: Ireland. Availability is national — a shortage in one country does not mean it is short everywhere.
1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.
Directly from the official medicines-agency registers that list Rasburicase: EMA shortages catalogue (EU), HPRA (Ireland). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.
Pharmacies, patient sites and newsrooms are welcome to embed the live status of Rasburicase — free, with attribution. Copy this snippet:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/rasburicase/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Rasburicase availability in Europe"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/rasburicase/">Rasburicase shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>